Gilead Sciences (NASDAQ:GILD) announced that the European Commission approved Trodelvy (sacituzumab govitecan-hziy) combined with Keytruda (pembrolizumab) for adults with PD-L1-positive metastatic triple-negative breast cancer.
Precision BioSciences (NASDAQ:DTIL) announced that the first patient has been dosed in the Phase 1/2 FUNCTION-DMD trial evaluating PBGENE-DMD for Duchenne muscular dystrophy.
Comstock (NYSE:LODE) announced the completion of its sale of legacy mining, processing, and related real estate entities to Mackay Precious Metals, a subsidiary of Mackay Gold & Silver Corp., in a transaction valued at more than $45 million.
XPENG (NYSE:XPEV) announced that its robotics business has secured more than US$900 million in funding from global investors, giving the unit a post-money valuation of more than US$6.3 billion.
Ecovyst, ECVT stock, Laurie Bergman, CFO appointment, Michael Feehan, corporate leadership, executive changes, chemical industry
Robo.ai (NASDAQ:AIIO) reported net revenue of US$55.1 million for the six months ended June 30, 2026.
X Financial (NYSE:XYF) reported second-quarter 2026 total net revenue of RMB993.6 million (US$146.4 million), marking a 56.3 percent year-over-year decline.
Tanker traffic through the Strait of Hormuz remained weak over the weekend, with fewer than 20 vessels crossing the key oil route as Iran and the United States exchanged threats.
Oculis (NASDAQ:OCS) announced that the first patient has been treated in PIONEER-1, a registrational trial evaluating Privosegtor for acute optic neuritis in patients with and without multiple sclerosis.
Endeavour Silver (NYSE:EXK) announced that the blockade at its Terronera Mine in Mexico has been removed, allowing operations at the site to resume on August 24, 2026.
GET YOUR GRAFA EDGE NOW
Sign up free to unlock this feature
We'll switch on a 30-day Edge trial as a welcome gift
